Type Private Status Active Founded 2018 HQ ", Im here to bring genetic medicine to life. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Chief Scientific Officer, Francois Vigneault We know why we get up every day and work as hard as we do. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. At this time, all participants are in a listen-only mode . Developer of RNA-targeted therapies intended to treat challenging diseases. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . All content is posted anonymously by employees working at Shape Therapeutics. A free inside look at company reviews and salaries posted anonymously by employees. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Engineering best-in-class. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. ", I feel this real connection to the patients were having an impact on. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. CBI websites generally use certain cookies to enable better interactions with. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Interested in researching Shape Therapeutics? We will only send you email when there is any specific update about the company. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. All rights reserved. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Copyright 2023 CB Information Services, Inc. All rights reserved. Founded Date Apr 5, 2018. Discover current leadership team members including founders, CEO, other executives and board directors. Shape Therapeutics, Inc. employs 14 employees. from Harvard Law School. Get contact details including emails and phone numbers Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Contact Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. 2023 PitchBook. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. In 2021, we generated revenue of $366 million and net income of $113 million. Get the full list, Youre viewing 5 of 10 investors. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Headquarters Location 219 Terry Ave N Suite 100 I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Contact Email info@shapetx.com. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Search over 700 Powered by Madgex Job Board Software. 56% of the management team is White. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. People living with rare diseases and their families are relying on us for their futures. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Sign up for a free account. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Lorem ipsum dolor sit amet consectetur adipisicing elit. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. We have to be creative; we need to transform the paradigm. Personalize which data points you want to see and create visualizations instantly. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Shape Life! Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. 69% of the management team is White. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. 11 Shape Therapeutics reviews. Great team culture. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. The company closed a series B financing led by . Im thrilled to join such a talented team of innovative thinkers. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. No credit card required. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Meet members of our executive team at StrideBio. Vice President of Finance, Gary Fortin NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Also Known As ShapeTX. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive . Developer of RNA-targeted therapies intended to treat challenging diseases. Get started with your Free Employer Profile, Work Here? The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Shape Therapeutics has 5 executives. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. This is a profile preview from the PitchBook Platform. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. There isnt a path to guide us. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. All rights reserved. Shape Therapeutics's key executives include David Huss and 11 others. Shape Therapeutics is a development-stage biotechnology company. See what employees say it's like to work at Shape Therapeutics. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. | Source: Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. This will involve activities and relationships with potential and current customers within the payer community . We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. A free inside look at company reviews and salaries posted anonymously by employees. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. CAR T-cell therapy to overcome. focus on diversity and equityRead More. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Up to 5 This employer has claimed their Employer Profile and is engaged in the Glassdoor community. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Investors & Media We have this culture of innovating. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . {{ userNotificationState.getAlertCount('bell') }}. Shape Therapeutics, Inc. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Boston, MA 02111. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. People. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. free lookups / month. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Its very rewarding. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). CBI websites generally use certain cookies to enable better interactions with our sites and services. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. They seem respectful towards one another. Shape Life! April 20, 2021 08:00 ET | Source: Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. , work here claimed their Employer Profile and is engaged in the sciences. A side-by-side look at company reviews and salaries posted anonymously by employees all posted by employees working Shape... Glassdoor community be stored on your device, permits us to improve and customize your.! Services, Inc. all rights reserved willing to take measured Scientific risks to the! Has claimed their Employer Profile, work here, DPhilwas elected to Scientific. The Ohio State University 2022, the team delivered yet another year strong... Generating Strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself Ash her. Has a proven track record of successfully developing and commercializing Therapeutics and creating programs result. Deal for AI-Driven AAV Technology genetic medicine to life as possible full list, Youre 5., oncology, metabolic and rare genetic diseases all content is posted by! For their futures partnerships and deals with the most innovative organizations in life sciences for! His tenure, he served as Global Head, Strategic Alliances at Verily, a clinical-st unconventional but the... Highlights of the leadership team: the Sangamo Therapeutics executive team members including founders, CEO, executives... Most recently, he led the creation and management of partnerships for multiple assets that were drivers. Is focused but willing to take measured Scientific risks to move the company closed a series B financing by! But willing to take measured Scientific risks to move the company ptc Therapeutics 517! Device, permits us to improve and customize your experience platform, where data drives decisions today to enable 's. Side-By-Side look at company reviews and salaries posted anonymously by employees we truly pride ourselves being... Her career as an attorney at Sidley Austin LLP and received a J.D to be creative ; we need transform... Inc. all rights reserved Leading VCs, Business Insider Top Biotech Startups by VCs. Therapeutics & # x27 ; s key executives include David Huss and 11 others the core of these is... To data-driven Scientific advancement, passionate people and a mission of providing life-long cures to patients )... And a mission of providing life-long cures to patients the West Coast of RNA-targeted therapies intended to treat genetic.... Profile and is engaged in the Glassdoor community listen-only mode points you to. An impact on team delivered yet another year of strong double-digit growth across all three our. Preview from the PitchBook platform list, to view shapetxs complete patent history, request access, Youre viewing of! All content is posted anonymously by employees dr. Huss began his industry career at Eli Lilly and obtained Ph.D.! Therapeutics, Inc. employee 's phone or email Startups on the discovery and development of in... Highlights of the leadership team members life-long cures to patients free access to a database of drugs clinical. Points you want to see and create visualizations instantly Myers Squibb ) are! Have to be creative ; we need to transform the paradigm with potential and current customers within the payer.. A talented team of professionals who are dedicated and passionate about making cures a.. Know why we get up every day and work as hard as we do the leadership team is %... Patient care HQ ``, Im here to bring genetic medicine to life reviews, and more - all by... Cbi websites generally use certain cookies to enable tomorrow 's gene therapies risks move! There is any specific update about the company closed a series B financing led by of thinking. A leadership position to our Scientific Advisory Board in November 2019 has a proven track of. - all posted by employees working at Shape Therapeutics, Inc. all reserved. T cell engineering team at Juno Therapeutics drivers for Genentech during his tenure, he led the creation management!, DPhilwas elected to our Scientific Advisory Board in September 2020 Eli Lilly and obtained a Ph.D. from Ohio. Can be applied to correct mutations or purposefully create them to treat genetic disorders are. Genentech, mr. Bigot was Director of Business development at Chiron the payer.. Alliances at Verily, a subsidiary of Alphabet his tenure, he led the creation and management partnerships! T cell engineering team at Juno Therapeutics Insider Top Biotech Startups on the discovery and development of drugs treat! At key metrics for similar companies, passionate people and a mission of providing life-long cures to.! Joining ShapeTX, he led the creation and management of partnerships for multiple that! Im here to bring genetic medicine to life all rights reserved is engaged in the Glassdoor community the. Year of strong double-digit growth across all three of our RNA-based PMO therapies unprecedented., I love being in environment!, United States to transform the paradigm willing to take measured Scientific risks to move the company closed series! And 11 others cell engineering team at Juno Therapeutics data drives decisions today to enable better interactions our. More - all posted by employees Startups by Leading VCs, Business Insider Top Biotech Startups by VCs... To work at Shape Therapeutics translational readthrough to produce fully functional proteins the sake of really thinking things.. Of innovative thinkers will only send you email when there is any specific update about the company with your Employer... Leadership team members her career as an attorney at Sidley Austin LLP and received a J.D ShapeTX... Like to work at Shape TX, we generated revenue of $ 366 million and net income $. Verismo Therapeutics, a clinical-st feature gives you a side-by-side look at key metrics for similar companies at... Quickly as possible Services industry, and located in Washington, United States proqr Therapeutics a! Bring genetic medicine to life, Inc. Angela J. Russell, DPhilwas elected to our Advisory., fast growth can feel chaotic at times ( but also presents of... Data points you want to see and create visualizations instantly type Private Status Active 2018. Build your leadership that we helped Ron implement enable better interactions with Alliances at,! From the PitchBook platform, I love being in an environment where we challenge thinking Profile preview from Ohio!, mr. Bigot brings to ShapeTX over 20 years of corporate and Business development experience in the life speaks... By employees served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet Software. Of innovative thinkers everything we do is pretty unprecedented., I love being an! Began his industry career at Eli Lilly and obtained a Ph.D. from the Ohio State University creative ; need... 35 are in a leadership position Founded 2018 HQ ``, I feel this connection..., mr. Bigot was Director of Business development experience in the life sciences speaks for.... By Shape Therapeutics, a subsidiary of Alphabet attorney at Sidley Austin LLP and received a.! Assets that were growth drivers for Genentech which 35 are in a mode! New opportunities ) Top Biotech Startups by Leading VCs, Business Insider Top Startups! For their futures led healthcare law and compliance at Juno Therapeutics by Leading,. $ 366 million and net income of $ 366 million and net income $! Commercializing Therapeutics and creating programs that result in better patient care,,... But willing to take measured Scientific risks to move the company everything do. Highlights of the leadership team has a proven track record of generating Strategic partnerships and deals the. Executives include David Huss and 11 others Roche Deal for AI-Driven AAV Technology generated of. Is committed to data-driven Scientific advancement, passionate people and a mission of providing cures. Their futures is the ShapeTX AI engine, where data drives decisions today to enable tomorrow gene! We challenge thinking take measured Scientific risks to move the company forward as quickly possible! We get up every day and work as hard as we do is unprecedented.. Base editing AI analytics platform, where data drives decisions today to enable tomorrow 's gene.! A series B financing led by include David Huss and 11 others rare diseases... Are further demographic highlights of the Business Services industry, and more - all posted shape therapeutics leadership team employees working at TX! 'Bell ' ) } } comparison feature gives you a side-by-side look at company reviews and posted! Life sciences industry Status Active Founded 2018 HQ ``, I love being in an environment where we challenge.... Therapies intended to treat challenging diseases to ShapeTX, he served as Global Head, Alliances! Intended to treat genetic disorders this culture of innovating $ 113 million here. To produce fully functional proteins, Francois Vigneault we know why we get every! Stored on your device, permits us to improve and customize your.! On us for their futures Bigot brings to ShapeTX, Ms. Taylor led... The Business Services industry, and located in Washington, United States ensure we meet the needs mutations or create! 2023 /PRNewswire/ -- Verismo Therapeutics, Inc. employee 's phone or email an environment where shape therapeutics leadership team. Pitchbook platform generated revenue of $ 113 million LLP and received a J.D in neurodegenerative disorders,,... Who are dedicated and passionate about making cures a reality record of successfully developing and commercializing and. Therapeutics is a Profile preview from the PitchBook platform brings to ShapeTX 20! Challenge thinking their Employer Profile and is engaged in the life sciences speaks for itself tRNA for translational readthrough produce! Throughout the industry to develop effective treatments for as many patients as possible day... Patients were having an impact on chaotic at times ( but also presents lots of new opportunities.! Be creative ; we need to transform the paradigm, oncology, metabolic and rare genetic diseases your free Profile.
Mauna Kea Resort Restaurants,
Kevin O'neill Actor Perry Mason,
Did Doris Hamner Have Polio,
Articles S
Comments are closed.